Drugmakers developing monthly weight loss drugs rather than weekly

Pfizer and Amgen are developing monthly GLP-1 shots with the goal being to make weight loss drugs more convenient and easier to maintain. Injections made by Wegovy and Zepbound are taken weekly. NBC News' Berkeley Lovelace, Jr. explains how users may benefit.

For more context and news coverage of the most important stories of our day, click here: https://www.nbcnews.com

» Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC » Subscribe to Here's the Scoop podcast: https://www.nbcnews.com/heres-the-scoop-daily-podcast » NBC News App: https://apps.nbcnews.com/mobile » Breaking News Alerts: https://link.nbcnews.com/join/5cj/breaking-news-signup?cid=sm_npd_nn_yt_bn-clip_190621 » Visit NBCNews.Com: http://nbcnews.to/ReadNBC » Find NBC News on Facebook: http://nbcnews.to/LikeNBC » Follow NBC News on Twitter: http://nbcnews.to/FollowNBC » Follow NBC News on Instagram: http://nbcnews.to/InstaNBC

#Drug #Health #Healthcare